Statistics for Evolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatment

Total visits

views
Evolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatment 0

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
Journal Article.pdf 3